RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

In a new episode of the video series STATus Report, a closer look at the reasons health secretary RFK Jr. cited for canceling contracts on mRNA vaccine research.

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

HHS Secretary Robert F. Kennedy Jr. used discredited and misrepresented studies to justify canceling research into ...

Jay Bhattacharya is director of the National Institutes of Health.